In another win for victims seeking compensation for defective transvaginal mesh devices, manufacturer Coloplast has agreed to pay $16 million in transvaginal mesh settlements to over 400 plaintiffs who suffered injury due to implant failure.
If plaintiffs in the suit approve the proposed settlement, each injured party will receive roughly $40,000 from Coloplast to treat injuries caused by side effects of the mesh inserts. Many of the plaintiffs are women who received the devices for treatment of pelvic organ prolapse and urinary incontinence, only to suffer pain, discomfort, infections, urinary problems, uncontrolled bleeding, and erosion of the mesh through organs and bodily tissues.
The settlement may signal good news for plaintiffs in other pending vaginal mesh cases, many of which have arisen since the release of a 2011 FDA report ordering 31 companies to investigate allegations of injury and side effects linked to transvaginal mesh implants. To date, at least three companies have settled similar cases, including:
- Endo Health – In June 2013, Endo Health agreed to pay several plaintiffs $54M in settlements.
- C.R. Bard – Bard was ordered to pay one victim $2M for its defective design of the Avaulta Plus implant in 2013.
- Johnson & Johnson – Although cases continue against the world’s largest pharmaceutical corporation, Johnson & Johnson’s Ethicon division was forced to pay a woman $11M in a transvaginal mesh settlement in 2013 for complications related to a failed Gynecare Prolift device.
As the fight for justice continues, we’ll always be ready with the latest news on surgical injury cases. Sign up for our free newsletter to get updates delivered right to you, or click the links on this page to find out more about the risks and alternatives to transvaginal mesh implants.